OVATIO Models: VR 6250, DR 6550, CRT 6750. Product Usage: OVATIO VR 6250, OVATIO DR 6550, PARADYM VR 8250, PARADYM DR 8550, PARADYM RF VR 9250, PARADYM RF DR 9550, INTENSIA VR 124 and INTENSIA DR 154 are indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT). OVATIO CRT 6750, PARADYM CRT-D 8750, PARADYM SonR 8770, PARADYM RF CRT-D 9750, PARADYM RF SonR 9770 and INTENSIA CRT-D 174 are indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life threatening arrhythmias. The devices are also indicated for the reduction of heart failure symptoms in medically optimized NYHA Functional Class III and IV patients with left ventricular ejection fraction of 35% or less, and a QRS duration of 150 ms or longer.
Publicado el 24 de mayo de 2017 · Inicio del retiro: 11 de abril de 2017
Resumen
FDA registra el retiro Z-2112-2017 de dispositivos médicos de Clase II, publicado el 24 de mayo de 2017 e iniciado el 11 de abril de 2017. Empresa responsable: Sorin Group Italia SRL - CRF; Estado: Finalizado; Cantidad reportada: 3096; Lote: Product Code: OH61U, OH60U, OH62U. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Sorin is notifying physicians that certain defibrillators' battery depletion may be undetectable.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Sorin Group Italia SRL - CRF
- Distribuidor
- US Nationwide Distribution
- Lote
- Product Code: OH61U, OH60U, OH62U
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- Italy
Retiros relacionados
- FDAPlatinium DR DF4 1540, Model Number TDF036U, UDI/GTIN 08031527015477, Implantable cardioverter defibrillator,4 de octubre de 2017
- FDAPlatinium VR DF4 1240, Model Number TDF035U, UDI/GTIN 08031527015460, Implantable cardioverter defibrillator,4 de octubre de 2017
- FDAPlatinium CRT-D 1741, Model Number TDF037U, UDI/GTIN 08031527015484, Implantable cardioverter defibrillator,4 de octubre de 2017
- FDAINTENSIA Models: VR 124, DR 154, CRT-D 174 Product Usage: OVATIO VR 6250, OVATIO DR 6550, PARADYM VR 8250,24 de mayo de 2017
- FDANormed General Instruments 503004541: Werber Countersink Cannulated for micro CBS Screws, AO 503004341: Werber24 de mayo de 2017
- FDABrennen Skin Graft Mesher. Surgical instrument designed to expand skin grafts'24 de mayo de 2017
Preguntas sobre este retiro
¿OVATIO Models: VR 6250, DR 6550, CRT 6750. Product Usage: OVATIO VR 6250, OVATIO DR 6550, PARADYM VR 8250, PARADYM DR 8550, PARADYM RF VR 9250, PARADYM RF DR 9550, INTENSIA VR 124 and INTENSIA DR 154 are indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT). OVATIO CRT 6750, PARADYM CRT-D 8750, PARADYM SonR 8770, PARADYM RF CRT-D 9750, PARADYM RF SonR 9770 and INTENSIA CRT-D 174 are indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life threatening arrhythmias. The devices are also indicated for the reduction of heart failure symptoms in medically optimized NYHA Functional Class III and IV patients with left ventricular ejection fraction of 35% or less, and a QRS duration of 150 ms or longer. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2112-2017 el 24 de mayo de 2017. Peligro reportado: Sorin is notifying physicians that certain defibrillators' battery depletion may be undetectable.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter